Ausgabe 10/2004
Inhalt (5 Artikel)
A Benefit-Risk Assessment of Inhaled Long-Acting β2-Agonists in the Management of Obstructive Pulmonary Disease
Milind P. Sovani, Christopher I. Whale, Anne. E. Tattersfield
Comparative Tolerability of Drug Treatment for Nocturnal Enuresis in Children
Dominik Müller, Charles C. Roehr, Paul Eggert
Calculation of Doses of Drugs in Solution
Daniel W. Wheeler, Dionysios D. Remoundos, Kim D. Whittlestone, Timothy P. House, David K. Menon
Haematological Effects of Interferon-β-1a (Rebif®) Therapy in Multiple Sclerosis
Peter Rieckmann, Paul O’Connor, Gordon S. Francis, Graham Wetherill, Enrica Alteri